2,3-diketopiperazine derivatives or their salts

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

51425214, 5142541, 544295, 544376, 544377, 544379, A61K 31496, A61K 31506, C07D40306, C07D40506, C07D40906

Patent

active

06153613&

ABSTRACT:
The present invention relates to a 2,3-diketopiperazine derivative or a salt thereof, which has inhibitory effect on platelet aggregation because of glycoprotein IIb/IIIa receptor antagonism and hence is useful as a prophylactic and therapeutic agent for diseases associated with platelet aggregation.
General formula ##STR1## wherein R.sup.1 represents a protected or unprotected amidino group; R.sup.2 represents a hydrogen atom or a carboxyl-protecting group; A represents a substituted or unsubstituted lower alkylene group; B represents --O--, --CONH--, --NHCO-- or --SO.sub.2 NH--; Y represents a substituted or unsubstituted lower alkylene group; and the broken line represents a single bond or a double bond.

REFERENCES:
patent: 4948892 (1990-08-01), Tanabe et al.
patent: 5877174 (1999-03-01), Ono et al.
Hori, et al., Chem Pharm Bull. 29, pp. 386-389 (1981).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2,3-diketopiperazine derivatives or their salts does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2,3-diketopiperazine derivatives or their salts, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,3-diketopiperazine derivatives or their salts will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1726060

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.